Merck & Co., (MRK) Financials
Merck & Co., (MRK) Historical Financial Statements and Key Metrics for 1994 - 2026
Full Merck & Co., financials for 1994 - 2026 are available in the
US Historical Financials dataset
All financial data is sourced direct from SEC 10-Q and 10-K filings, restatements are included.
Merck & Co., Income Statements
(in $ 000,000's)
| Quarter End | Revenue | Gross Profit | Operating Income | Net Income | EBITDA | EPS |
| 2026-Jun-30 | 16,607 | 12,212 (73.5 %) | -683 (-4.1 %) | -1,335 (-8.0 %) | 1,425 | -0.54 |
| 2026-Mar-31 | 16,286 | 13,342 (81.9 %) | -1,884 (-11.6 %) | -4,240 (-26.0 %) | -2,022 | -1.72 |
| 2025-Dec-31 | 16,400 | 15,204 (92.7 %) | 8,736 (53.3 %) | 2,963 (18.1 %) | 4,341 | 1.19 |
| 2025-Sep-30 | 17,276 | 13,421 (77.7 %) | 6,554 (37.9 %) | 5,785 (33.5 %) | 8,226 | 2.32 |
| 2025-Jun-30 | 0 | 0 (0.0 %) | 0 (0.0 %) | 0 (0.0 %) | 0 | 0.00 |
| 2025-Mar-31 | 0 | 0 (0.0 %) | 0 (0.0 %) | 0 (0.0 %) | 0 | 0.00 |
| 2024-Dec-31 | 15,624 | 14,700 (94.1 %) | 6,820 (43.7 %) | 3,743 (24.0 %) | 6,929 | 1.49 |
Full historical income statements for 1994 - 2026 is included in the
US Historical Financials dataset.
Merck & Co., Balance Sheets
(in $ 000,000's)
| Quarter End | Total Assets | Total Liabilities | Total Debt | Total Equity | Cash & Equivalents |
| 2026-Jun-30 | 129,802 | 87,818 | 53,906 | 41,933 | 7,141 |
| 2026-Mar-31 | 128,685 | 82,754 | 49,117 | 45,878 | 5,702 |
| 2025-Dec-31 | 136,866 | 84,204 | 50,534 | 52,606 | 14,565 |
| 2025-Sep-30 | 129,546 | 77,639 | 41,374 | 51,850 | 18,214 |
| 2025-Jun-30 | 117,523 | 68,463 | 35,402 | 48,993 | 8,622 |
| 2025-Mar-31 | 115,122 | 66,722 | 34,844 | 48,335 | 9,228 |
| 2024-Dec-31 | 117,106 | 70,734 | 37,111 | 46,313 | 13,689 |
Full historical balance sheet data for 1994 - 2026 is included in the
US Historical Financials dataset.
Merck & Co., Cash Flow Statements
(in $ 000,000's)
| Quarter End | Operating Cash Flow | Investing | Financing | Free Cash Flow |
| 2026-Jun-30 | 5,370 | -5,602 | 1,762 | 4,477 |
| 2026-Mar-31 | 3,918 | -10,210 | -2,981 | 2,927 |
| 2025-Dec-31 | 2,857 | -11,201 | 4,751 | 1,824 |
| 2025-Sep-30 | 7,822 | -283 | 2,638 | 6,835 |
| 2025-Jun-30 | 3,293 | -770 | -3,556 | 2,529 |
| 2025-Mar-31 | 2,500 | -1,487 | -5,755 | 1,172 |
| 2024-Dec-31 | 3,450 | -1,444 | -3,009 | 2,513 |
Full historical cash flow data for 1994 - 2026 is included in the
US Historical Financials dataset.
Merck & Co., Key Valuation and Operating Metrics
| Quarter End | Market Capitalization ($ 000,000's) |
Enterprise Value ($ 000,000's) |
Price/Earnings ($ 000,000's) |
Price/Sales ($ 000,000's) |
Price/Book ($ 000,000's) |
| 2026-Jun-30 | 317,654 | 364,711 | 19.13 | -59.49 | 7.58 |
| 2026-Mar-31 | 297,359 | 341,149 | 18.26 | -17.48 | 6.48 |
| 2025-Dec-31 | 262,089 | 298,058 | 15.98 | 22.11 | 4.98 |
| 2025-Sep-30 | 209,657 | 232,862 | 12.14 | 9.06 | 4.04 |
| 2025-Jun-30 | 0 | 0 | 0.00 | 0.00 | 0.00 |
| 2025-Mar-31 | 0 | 0 | 0.00 | 0.00 | 0.00 |
| 2024-Dec-31 | 252,779 | 276,648 | 16.18 | 16.88 | 5.46 |
Full historical valuation and operating metrics for 1994 - 2026 are included in the
US Historical Financials dataset.